{
  "@context": "aku-v2",
  "@type": "procedure",
  "@id": "vasc:fmd:angioplasty",
  "metadata": {
    "version": "2.0.0",
    "created": "2026-01-07T03:17:00.000Z",
    "updated": "2026-01-07T03:17:00.000Z",
    "contributors": ["knowledge-graph-agent"],
    "confidence": 0.92,
    "status": "pending-quality-check"
  },
  "classification": {
    "domain_path": "health-sciences/medicine/surgery/vascular/pathology/genetic-disorders",
    "type": "endovascular-procedure",
    "difficulty": "advanced",
    "importance": "high"
  },
  "content": {
    "title": "Angioplasty for FMD",
    "description": "Percutaneous transluminal angioplasty as treatment for symptomatic fibromuscular dysplasia",
    "key_concepts": [
      {
        "concept": "Indications",
        "details": "Renovascular hypertension with renal FMD, symptomatic carotid FMD"
      },
      {
        "concept": "Technique",
        "details": "Balloon angioplasty usually sufficient; stenting generally not required"
      },
      {
        "concept": "Renal FMD Results",
        "details": "Technical success >95%; blood pressure cure/improvement in 60-80%"
      },
      {
        "concept": "Carotid FMD",
        "details": "Reserved for symptomatic lesions; lower threshold for intervention if dissection"
      }
    ],
    "clinical_significance": "Angioplasty is first-line treatment for symptomatic FMD stenosis"
  },
  "provenance": {
    "primary_sources": ["Trinquart L et al. J Hypertens 2010"]
  }
}
